Recurrent Pregnancy Loss in Patna: Causes, Diagnosis & How HomeIVF Can Help You Carry to Term

Recurrent pregnancy loss is clinically defined as two or more pregnancy losses before the foetus reaches viability, generally before 20 weeks of gestation. While a single miscarriage affects up to 15–20% of recognised pregnancies and is often a random chromosomal event, RPL signals that an underlying, potentially correctable factor may be at play.

In Patna, RPL is not a rare edge case. The city's fertility specialists have noted a steady increase in couples seeking evaluation after repeated losses, driven partly by improved awareness and partly by real rises in predisposing conditions. Women in localities like Rajendra Nagar and Kankarbagh who have experienced two or more losses are often well within the window where investigation makes a meaningful clinical difference.

RPL affects women across all age groups, though the risk climbs significantly after 35. Importantly, RPL is a couple's diagnosis — male-factor contributions, including sperm DNA fragmentation, are increasingly recognised as contributors and must be part of any thorough workup. HomeIVF's approach treats RPL as a shared investigation from day one.

The causes of RPL are multiple and often overlapping. Understanding them is the first step toward a pregnancy that reaches term.

**Chromosomal and Genetic Factors:** The most frequent cause of individual miscarriages — random chromosomal errors in the embryo — can become a pattern when either partner carries a balanced chromosomal translocation. Karyotyping of both partners is therefore a foundational test in RPL workup.

**Uterine Structural Abnormalities:** Septate uterus, submucosal fibroids, intrauterine adhesions (Asherman's syndrome), and polyps can all physically disrupt implantation or early placentation. These are correctable with targeted intervention.

**Antiphospholipid Syndrome (APS):** This autoimmune clotting disorder is found in roughly 15% of RPL cases and is among the most treatable causes. Simple blood tests — anticardiolipin antibodies and lupus anticoagulant — can identify it.

**Hormonal Imbalances:** Poorly controlled hypothyroidism, elevated prolactin, and insulin resistance linked to PCOS are all common in Patna's population and directly increase miscarriage risk. Correcting TSH to below 2.5 mIU/L in early pregnancy, for instance, substantially reduces RPL risk in thyroid patients.

**Sperm DNA Fragmentation:** Elevated sperm DNA damage reduces embryo quality and is an underappreciated RPL contributor that standard semen analysis misses entirely.

RPL does not always announce itself dramatically. Some losses occur before a woman knows she is pregnant — presenting only as a late or unusually heavy period. Others involve confirmed pregnancies that end in the first trimester with cramping and bleeding. Understanding when to escalate from watchful waiting to active investigation is critical.

**Seek specialist evaluation if you have experienced:** Two or more confirmed pregnancy losses at any gestational age; one loss after 10 weeks (when chromosomal causes are less likely and structural or immune causes more probable); recurrent biochemical pregnancies detected on home tests that do not progress; or a history of one loss combined with difficulty conceiving for more than 12 months.

For women in Patna over the age of 35, many specialists now recommend investigation after even a single loss at 10 weeks or beyond, given the narrower reproductive window.

HomeIVF's remote consultation model means couples in Boring Road or Patliputra Colony do not need to navigate crowded hospital OPDs to get a first expert opinion. A structured video consultation with a senior fertility specialist can be booked within 24–48 hours, initiating the diagnostic pathway without delay.

A thorough RPL evaluation is not a single test — it is a coordinated panel that investigates multiple biological systems simultaneously. HomeIVF's RPL workup protocol, reviewed and approved by the HomeIVF Medical Board, covers the following domains.

**Genetic Testing:** Karyotyping of both partners to detect balanced translocations or inversions. Products of conception (POC) testing after a loss can determine whether the miscarriage was chromosomally normal or abnormal — a clinically important distinction.

**Uterine Assessment:** 3D transvaginal ultrasound is the first-line investigation for uterine anatomy. Saline infusion sonography (SIS) or hysteroscopy may follow if a uterine defect is suspected.

**Thrombophilia and Immune Panel:** Anticardiolipin antibodies (IgG and IgM), lupus anticoagulant, beta-2 glycoprotein antibodies, Factor V Leiden mutation, and MTHFR polymorphisms.

**Hormonal Profile:** TSH, free T4, prolactin, fasting insulin, AMH (to assess ovarian reserve), and a Day 2–3 FSH/LH/E2 panel.

**Sperm DNA Fragmentation Index (DFI):** Ideally measured by TUNEL or SCSA assay. A DFI above 25% is associated with significantly elevated miscarriage risk.

HomeIVF coordinates sample collection and dispatch from the patient's home in Patna, reducing the logistical burden on couples who are already emotionally exhausted.

Treatment for RPL is only meaningful when it is cause-specific. HomeIVF's senior specialists design individualised management plans rather than applying one-size-fits-all protocols.

**For APS:** Low-dose aspirin combined with low-molecular-weight heparin (LMWH) initiated before conception significantly improves live birth rates — a well-established protocol supported by randomised controlled evidence.

**For Uterine Anomalies:** Operative hysteroscopy to correct a uterine septum, remove polyps, or lyse adhesions is a day-procedure that dramatically improves implantation and ongoing pregnancy rates.

**For Thyroid Dysfunction:** Levothyroxine titrated to maintain pre-conception TSH below 2.5 mIU/L, with close monitoring into the first trimester.

**For High Sperm DFI:** Antioxidant therapy, lifestyle modification, and in selected cases, testicular sperm extraction (TESE) to bypass epididymal sperm DNA damage.

**For Unexplained RPL:** Progesterone supplementation in early pregnancy (the PRISM trial evidence base), alongside empirical low-dose aspirin, is offered with transparent counselling about the evidence level.

**For Chromosomal Causes:** IVF with Preimplantation Genetic Testing for Aneuploidy (PGT-A) selects chromosomally normal embryos before transfer, markedly reducing miscarriage risk. HomeIVF offers IVF packages starting from ₹1.5 lakh for eligible Patna couples.

One of the most common anxieties for couples seeking RPL care in Patna is uncertainty about what the process will cost and how long it will take. HomeIVF prioritises transparency on both counts.

**Diagnostic Phase (Weeks 1–4):** The full RPL panel — genetic, immunological, hormonal, and sperm testing — can typically be completed within two to four weeks when home sample collection is coordinated efficiently. Costs vary by the specific tests ordered, and HomeIVF's care coordinator provides a test-by-test breakdown before any sample is collected.

**Treatment Phase (Weeks 4–16+):** Simple hormonal corrections (thyroid, prolactin) may show impact within one to two cycles. Surgical correction of uterine anomalies is typically a day procedure. IVF with PGT-A, when indicated, spans approximately four to six weeks per cycle.

**Monitoring Phase:** HomeIVF's home-monitoring model means that once treatment is underway, serial beta-hCG checks, progesterone monitoring, and early viability scans are coordinated locally in Patna — in many cases through empanelled scan centres near Kankarbagh or Rajendra Nagar — minimising travel and emotional disruption during the most anxious weeks of a new pregnancy.

For couples who have experienced repeated pregnancy loss, every early pregnancy week is laden with anxiety. The conventional model — where patients travel to a clinic and wait in a shared waiting room for a five-minute consultation — is particularly ill-suited to RPL care.

HomeIVF delivers senior-specialist care at home through a combination of telehealth consultations, coordinated home blood draws, and real-time digital reporting. For Patna patients, this means:

**Faster escalation when needed:** A rising beta-hCG that plateaus can be flagged and reviewed by a senior specialist within hours, not days.

**Reduced infection and travel risk:** Particularly relevant for immunologically vulnerable RPL patients on heparin or progesterone supplementation.

**Continuity of care:** The same specialist team follows a patient from initial RPL investigation through conception and into the early weeks of the next pregnancy — the highest-risk window.

**Psychological support integration:** HomeIVF's care coordinators in Patna are trained to signpost couples to counselling resources, recognising that RPL's psychological toll is as real as its physical dimension.

Couples from Boring Road to Patliputra Colony have reported that the home-monitoring model removed one of their biggest barriers: the fear of falling apart emotionally in a clinical waiting room.

Despite Patna being Bihar's capital and a growing medical hub, couples seeking RPL care still face identifiable structural barriers.

**Fragmented care pathways:** Many couples see a general gynaecologist after a first loss, a different specialist after a second, and struggle to integrate results across providers. HomeIVF provides a single, co-ordinated care record.

**Awareness gaps:** In many families across Patna — including in well-educated households near Boring Road — RPL is still attributed to stress or fate rather than investigated medically. HomeIVF's content and consultation model directly addresses this by providing evidence-based education at the first point of contact.

**Stigma and privacy:** Fertility concerns remain sensitive in Bihar's social fabric. HomeIVF's home-based model means that neighbours and extended family need not know that a couple is seeking investigation — consultations happen by video, samples are collected discreetly at home, and reports are shared digitally.

**Geographic access:** Couples from districts outside Patna who travel to the city for fertility care can use HomeIVF to complete most of their workup before arriving, making in-person visits more targeted and productive.

The HomeIVF Medical Board has specifically designed the RPL care pathway to be navigable for Patna couples — from first consultation to confirmed ongoing pregnancy — with minimal physical displacement and maximum clinical rigour.